| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP, Controllership | Gvp, Chief Accounting Officer
2 companies
Burkhart Erin is a Gvp, Chief Accounting Officer at BMRN, with reported holdings spanning 2 companies. Recent filings cover 0 purchases and 5 sales. Those positions are worth an estimated $1.1M at current prices.
Our model assigns Burkhart Erin a strong insider score of 72/100, based on 5 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +24.4%.
Burkhart Erin's largest disclosed position is in BMRN as Gvp, Chief Accounting Officer, worth about $841K. The recent filings there lean toward selling, a net 7,425 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 20, 2025 | BMRN Biomarin Pharmaceutical Inc | Gvp, Chief Accounting Officer | Sell10b5-1 | 1,786 | $59.31 | $105,927.66 | -11.2% | -4.2% | -16.2% | |
| Mar 19, 2025 | BMRN Biomarin Pharmaceutical Inc | Gvp, Chief Accounting Officer | Sell10b5-1 | 1,295 | $71.52 | $92,618.40 | -7.1% | -22.9% | -22.8% | |
| Feb 24, 2025 | BMRN Biomarin Pharmaceutical Inc | Gvp, Chief Accounting Officer | Sell10b5-1 | 1,344 | $68.38 | $91,902.72 | -9.3% | -15.8% | -9.3% | |
| Aug 13, 2024 | BMRN Biomarin Pharmaceutical Inc | Gvp, Chief Accounting Officer | Sell10b5-1 | 714 | $90.00 | $64,260.00 | -4.7% | -27.1% | -35.9% | |
| Apr 10, 2024 | BMRN Biomarin Pharmaceutical Inc | Gvp, Chief Accounting Officer | Sell10b5-1 | 2,286 | $90.00 | $205,740.00 | -12.4% | -8.0% | -37.6% |